Park, Jonathan J.
Codina, Adan
Ye, Lupeng
Lam, Stanley
Guo, Jianjian
Clark, Paul
Zhou, Xiaoyu
Peng, Lei
Chen, Sidi
Article History
Received: 18 August 2022
Accepted: 22 November 2022
First Online: 1 December 2022
Declarations
:
: This study has received institutional regulatory approval. All recombinant DNA and biosafey work was performed under the guidelines of Yale Environment, Health and Safety (EHS) Committee with an approved protocol (Chen-rDNA-15–45; Chen-rDNA-18-45). All animal work was performed under the guidelines of Yale Institutional Animal Care & Use Committee (IACUC) with an approved protocol (Chen-2018-20068).
: Not applicable.
: No competing interest related to this study. SC is a (co)founder of EvolveImmune Tx, Cellinfinity Bio, Chen Consult, Chen Tech, all unrelated to this study.